The Glycomics or Glycobiology Market Overview 2025 report reveals that the market size has grown significantly over the past few years, with projections indicating further expansion.
The market size for Glycomics or Glycobiology has seen quick growth recently. The market was worth $1.85 billion in 2024 and is projected to reach $2.13 billion in 2025, with a CAGR of 15.2%.
The Glycomics or Glycobiology market is projected to grow to a market size of $4.03 billion by the year 2029. The growth rate during this period is forecasted to be at a compound annual growth rate (CAGR) of 17.2%.
Download Your Free Sample of the 2025 Glycomics or Glycobiology Market Report and Uncover Key Trends Now!The key drivers in the glycomics or glycobiology market are:
• The implementation of glycan-focused artificial intelligence (AI) and data analytics.
• The expansion in glycobiology-based drug development.
• The incorporation of glycomics in the process of disease biomarker discovery and personalized medicine.
• The development and use of glycan-based therapeutics.
The glycomics or glycobiology market covered in this report is segmented –
1) By Product: Enzymes, Kits, Reagents And Chemicals, Instruments, Carbohydrates
2) By Application: Drug Discovery And Development, Disease Diagnostics, Other Applications
3) By End-User: Academic Research Institutes, Pharmaceutical And Biotechnology Companies, Clinical Laboratories
The key trends in the glycomics or glycobiology market are:
• Cross-disciplinary collaborations in the field are emerging as a significant trend.
• Studies highlighting the role of glycosylation patterns in disease mechanisms are shaping the market.
• There is an innovative shift towards precision medicine and personalized therapies based on glycans.
• Advancements in glycoanalytical tools and their use in immunotherapy and vaccines are emerging trends in this market.
Major companies in the glycomics or glycobiology market are:
• Aligent Technologies Inc.
• Bruker Corporation
• Merck Co. & KgaA
• New England Biolabs Inc.
• Danaher Corporation
• Shimadzu Corporation
• ProZyme Inc.
• Takara Bio Inc.
• Asparia Glycomics SL
• Lectenz Bio
• Chemily Glycoscience LLC
• Z Biotech LLC
• RayBiotech Inc.
• Thermo Fisher Scientific Inc.
• Promega Corporation
• Bio-Techne Corp.
• AMS Bio LLC
• Ludger Ltd.
• CD BioGlyco Ltd.
• GlycoDiag SAS
• Kode Biotech Limited
• Glyxera GmBH
• Glycomix Ltd.
• R&D Systems Inc.
North America was the largest region in the glycomics or glycobiology market share in 2024